| # | Drug | Count |
|---|---|---|
| 0 | OCTREOTIDE ACETATE | 44 |
| 1 | HYDROCHLOROTHIAZIDE | 22 |
| 2 | LOPERAMIDE HYDROCHLORIDE | 22 |
| 3 | LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE | 22 |
| 4 | METFORMIN | 22 |
| 5 | GLYBURIDE | 20 |
| 6 | LINAGLIPTIN | 20 |
| 7 | QUINAPRIL HYDROCHLORIDE | 20 |
| 8 | ROSUVASTATIN | 18 |
| 9 | AMLODIPINE BESYLATE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUINAPRIL HYDROCHLORIDE | 20 | 0.0025 |
| 1 | OCTREOTIDE ACETATE | 44 | 0.0014 |
| 2 | LINAGLIPTIN | 20 | 0.0011 |
| 3 | TELOTRISTAT ETHYL | 5 | 0.0009 |
| 4 | GLYBURIDE | 20 | 0.0008 |
| 5 | PAMIDRONATE DISODIUM | 2 | 0.0006 |
| 6 | LOPERAMIDE HYDROCHLORIDE | 22 | 0.0005 |
| 7 | EVEROLIMUS TABLETS | 7 | 0.0004 |
| 8 | LANREOTIDE ACETATE | 3 | 0.0004 |
| 9 | LUTETIUM LU 177 DOTATATE | 2 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Thiazide Diuretic [EPC] | 22 |
| 1 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 20 |
| 2 | Sulfonylurea [EPC] | 20 |
| 3 | HMG-CoA Reductase Inhibitor [EPC] | 16 |
| 4 | Kinase Inhibitor [EPC] | 11 |
| 5 | mTOR Inhibitor Immunosuppressant [EPC] | 11 |
| 6 | Calcium Channel Blocker [EPC] | 10 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 10 |
| 8 | Alkylating Drug [EPC] | 6 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 20 | 0.0006 |
| 1 | Sulfonylurea [EPC] | 20 | 0.0002 |
| 2 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 3 | Thiazide Diuretic [EPC] | 22 | 0.0001 |
| 4 | Topoisomerase Inhibitor [EPC] | 5 | 0.0001 |
| 5 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 6 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 16 | 0.0000 |
| 8 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 10 | 0.0000 |